Detection of muscle wasting in patients with chronic heart failure using C -terminal agrin fragment: Results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

Lisa Steinbeck, Nicole Ebner, Miroslava Valentova, Tarek Bekfani, Sebastian Elsner, Pius Dahinden, Stefan Hettwer, Nadja Scherbakov, Jörg C. Schefold, Anja Sandek, Jochen Springer, Wolfram Doehner, Stefan D. Anker, Stephan Von Haehling

Research output: Contribution to journalArticlepeer-review

Abstract

Aims Skeletal muscle wasting affects 20% of patients with chronic heart failure and has serious implications for their activities of daily living. Assessment of muscle wasting is technically challenging. C-terminal agrin-fragment (CAF), a breakdown product of the synaptically located protein agrin, has shown early promise as biomarker of muscle wasting. We sought to investigate the diagnostic properties of CAF in muscle wasting among patients with heart failure. Methods and results We assessed serum CAF levels in 196 patients who participated in the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Muscle wasting was identified using dual-energy X-ray absorptiometry (DEXA) in 38 patients (19.4%). Patients with muscle wasting demonstrated higher CAF values than those without (125.1 ± 59.5 pmol/L vs. 103.8 ± 42.9 pmol/L, P = 0.01). Using receiver operating characteristics (ROC), we calculated the optimal CAF value to identify patients with muscle wasting as >87.5 pmol/L, which had a sensitivity of 78.9% and a specificity of 43.7%. The area under the ROC curve was 0.63 (95% confidence interval 0.56-0.70). Using simple regression, we found that serum CAF was associated with handgrip (R = - 0.17, P = 0.03) and quadriceps strength (R = - 0.31, P <0.0001), peak oxygen consumption (R = - 0.5, P <0.0001), 6-min walk distance (R = - 0.32, P <0.0001), and gait speed (R = - 0.2, P = 0.001), as well as with parameters of kidney and liver function, iron metabolism and storage. Conclusion CAF shows good sensitivity for the detection of skeletal muscle wasting in patients with heart failure. Its assessment may be useful to identify patients who should undergo additional testing, such as detailed body composition analysis. As no other biomarker is currently available, further investigation is warranted.

Original languageEnglish
Pages (from-to)1283-1293
Number of pages11
JournalEuropean Journal of Heart Failure
Volume17
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

Keywords

  • Agrin
  • Biomarker
  • Heart Failure
  • Muscle wasting
  • Sarcopenia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Detection of muscle wasting in patients with chronic heart failure using C -terminal agrin fragment: Results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)'. Together they form a unique fingerprint.

Cite this